Online citations, reference lists, and bibliographies.

Magnetic Iron Oxide Nanoparticles For Drug Delivery: Applications And Characteristics

Thomas Vangijzegem, Dimitri Stanicki, Sophie Laurent
Published 2019 · Medicine, Materials Science
Cite This
Download PDF
Analyze on Scholarcy
Share
ABSTRACT Introduction: For many years, the controlled delivery of therapeutic compounds has been a matter of great interest in the field of nanomedicine. Among the wide amount of drug nanocarriers, magnetic iron oxide nanoparticles (IONs) stand out from the crowd and constitute robust nanoplatforms since they can achieve high drug loading as well as targeting abilities stemming from their remarkable properties (magnetic and biological properties). These applications require precise design of the nanoparticles regarding several parameters which must be considered together in order to attain highest therapeutic efficacy. Areas covered: This short review presents recent developments in the field of cancer targeted drug delivery using magnetic nanocarriers as drug delivery systems. Expert opinion: The design of nanocarriers enabling efficient delivery of therapeutic compounds toward targeted locations is one of the major area of research in the targeted drug delivery field. By precisely shaping the structural properties of the iron oxide nanoparticles, drugs loaded onto the nanoparticles can be efficiently guided and selectively delivered toward targeted locations. With these goals in mind, special attention should be given to the pharmacokinetics and in vivo behavior of the developed nanocarriers.
This paper references
10.1016/j.colsurfb.2016.03.071
PSMA targeted docetaxel-loaded superparamagnetic iron oxide nanoparticles for prostate cancer.
Prashanth K B Nagesh (2016)
10.1016/J.JALLCOM.2016.09.083
Metal ferrite nanoparticles: Synthesis, characterization, and studies on decontamination of sulfur mustard
J. Praveen Kumar (2017)
10.1074/jbc.M506740200
Tumor Cells Enhance Their Own CD44 Cleavage and Motility by Generating Hyaluronan Fragments*
Kazuki N. Sugahara (2006)
10.2217/17435889.2.1.23
Recent advances on surface engineering of magnetic iron oxide nanoparticles and their biomedical applications.
Ajay Kumar Gupta (2007)
10.1016/j.jconrel.2011.01.024
Doxorubicin loaded iron oxide nanoparticles overcome multidrug resistance in cancer in vitro.
Forrest M Kievit (2011)
10.1038/nmat3776
Stimuli-responsive nanocarriers for drug delivery.
Simona Mura (2013)
10.3322/canjclin.39.6.399
Cancer statistics.
N Dubrawsky (1989)
10.2147/IJN.S110542
Remote magnetic targeting of iron oxide nanoparticles for cardiovascular diagnosis and therapeutic drug delivery: where are we now?
Michael Bietenbeck (2016)
Clinical applications of magnetic nanoparticles
Thanh NTK (2018)
10.3322/caac.21332
Cancer statistics, 2016
Rebecca L. Siegel Mph (2016)
10.3390/ijms16048070
Iron Oxide Nanoparticles for Magnetically-Guided and Magnetically-Responsive Drug Delivery
Joan Ramis Estelrich (2015)
10.1021/acs.chemrev.5b00589
Targeted Drug Delivery with Polymers and Magnetic Nanoparticles: Covalent and Noncovalent Approaches, Release Control, and Clinical Studies.
Karel Ulbrich (2016)
10.1039/b815548h
Magnetic nanoparticles: synthesis, functionalization, and applications in bioimaging and magnetic energy storage.
Natalie A. Frey (2009)
10.1002/JPS.21103
Cisplatin-incorporated hyaluronic acid nanoparticles based on ion-complex formation.
Young-Il Jeong (2008)
10.3109/1061186X.2015.1052072
Hyaluronic acid targeting of CD44 for cancer therapy: from receptor biology to nanomedicine*
George Mattheolabakis (2015)
10.1002/wnan.1389
pH-Sensitive stimulus-responsive nanocarriers for targeted delivery of therapeutic agents.
Mahdi Karimi (2016)
10.3390/ijms141121266
Magnetic Nanoparticles: Surface Effects and Properties Related to Biomedicine Applications
Bashar Issa (2013)
10.1088/1468-6996/16/2/023501
Recent progress on magnetic iron oxide nanoparticles: synthesis, surface functional strategies and biomedical applications
Wei Wu (2015)
10.1039/SA9731000072
The President and Society for Analytical Chemistry Gold Medallist
Young-wook Jun (1973)
10.1016/J.PROGPOLYMSCI.2011.02.001
Chitosan—A versatile semi-synthetic polymer in biomedical applications
Mamoni Dash (2011)
Superparamagnetic iron oxide nanoparticles conjugatedwith folic acid for dual target-specific drug delivery and MRI in cancer
Y Huang (2017)
10.1021/ja908117a
Gold Nanoparticles for the Improved Anticancer Drug Delivery of the Active Component of Oxaliplatin
Sarah D. Brown (2010)
10.1016/j.ijbiomac.2017.03.137
Artemisinin loaded chitosan magnetic nanoparticles for the efficient targeting to the breast cancer.
Subramanian Natesan (2017)
10.1038/s41598-017-13049-0
Use of RNAi technology to develop a PRSV-resistant transgenic papaya
R. Jia (2017)
10.1088/1674-1056/23/7/078401
Hybrid phase-locked loop with fast locking time and low spur in a 0.18-um CMOS process
Siheng Zhu (2014)
10.1155/2012/247597
Antitumor Activity of Artemisinin and Its Derivatives: From a Well-Known Antimalarial Agent to a Potential Anticancer Drug
María del Pilar Crespo-Ortiz (2012)
10.2147/IJN.S129300
Protein corona: a new approach for nanomedicine design
Văn Hồng Nguyên (2017)
10.1016/J.JMMM.2017.09.018
A simple approach to design chitosan functionalized Fe3O4 nanoparticles for pH responsive delivery of doxorubicin for cancer therapy
Mahesh G Adimoolam (2018)
10.1155/2015/413076
Paclitaxel and Its Evolving Role in the Management of Ovarian Cancer
Nirmala Chandralega Kampan (2015)
10.1002/smll.200801647
Functionalized nanoparticles with long-term stability in biological media.
Chen Fang (2009)
10.1002/wnan.1467
Protein corona and nanoparticles: how can we investigate on?
Francesca Pederzoli (2017)
10.1021/ic202197g
Cisplatin-tethered gold nanoparticles that exhibit enhanced reproducibility, drug loading, and stability: a step closer to pharmaceutical approval?
Gemma E. Craig (2012)
10.1016/j.addr.2009.11.002
Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging.
Omid Veiseh (2010)
This review provides relevant information concerning major aspects of the protein corona formation, characterization and consequences on the biological properties of nanomaterials
Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications
P Reimer (2003)
10.1016/j.ejps.2014.05.021
Synthesis of Doxorubicin loaded magnetic chitosan nanoparticles for pH responsive targeted drug delivery.
Gozde Unsoy (2014)
10.1517/17425247.2014.924501
Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges
Sophie Laurent (2014)
10.1016/j.ejpb.2016.01.017
Pharmaceutical formulation of HSA hybrid coated iron oxide nanoparticles for magnetic drug targeting.
Jan Zaloga (2016)
10.1088/0957-4484/19/46/465608
The development of stable aqueous suspensions of PEGylated SPIONs for biomedical applications.
Kerdiles Herve (2008)
10.1016/j.ejmech.2014.05.078
Multifunctionalization of magnetic nanoparticles for controlled drug release: a general approach.
Alfonso Latorre (2014)
10.1088/0957-4484/24/5/055705
A new approach to follow the formation of iron oxide nanoparticles synthesized by thermal decomposition.
Sarah Belaïd (2013)
Cancer theranostics: the rise of targeted nanoparticles
AJ Cole (2011)
10.1038/s41598-016-0028-x
Ror2 signaling regulates Golgi structure and transport through IFT20 for tumor invasiveness
Michiru Nishita (2016)
10.1016/j.ejphar.2014.07.041
Gemcitabine: metabolism and molecular mechanisms of action, sensitivity and chemoresistance in pancreatic cancer.
Lucas de Sousa Cavalcante (2014)
10.1038/srep44735
Doxorubicin induces cardiotoxicity through upregulation of death receptors mediated apoptosis in cardiomyocytes
Liqun Zhao (2017)
10.1016/j.biopha.2014.04.003
Chitosan magnetic nanoparticles for pH responsive Bortezomib release in cancer therapy.
Gozde Unsoy (2014)
10.1088/2043-6254/AA5E23
Magnetic inductive heating of organs of mouse models treated by copolymer coated Fe 3 O 4 nanoparticles
Hồng Nam Phạm (2017)
10.1016/j.nano.2011.05.016
Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging.
Suphiya Parveen (2012)
10.1039/C6RA00347H
Ultra-large-scale production of ultrasmall superparamagnetic iron oxide nanoparticles for T1-weighted MRI
Yuanpeng Rui (2016)
10.3390/jfb3030615
Biocompatibility of Chitosan Carriers with Application in Drug Delivery
Susana Cruz Rodrigues (2012)
10.1002/(SICI)1097-4628(19970103)63:1<125::AID-APP13>3.0.CO;2-4
Novel hydrophilic chitosan‐polyethylene oxide nanoparticles as protein carriers
Pilar Abad Calvo (1997)
10.1016/j.ijpharm.2008.07.006
Novel method of doxorubicin-SPION reversible association for magnetic drug targeting.
Emilie Munnier (2008)
10.1016/j.bbagen.2017.01.035
Multifunctionalized iron oxide nanoparticles for selective targeting of pancreatic cancer cells.
Sara Maria Trabulo (2017)
10.3390/ijms17030380
A RNA-DNA Hybrid Aptamer for Nanoparticle-Based Prostate Tumor Targeted Drug Delivery
J. H. C. Leach (2016)
10.1038/nrd1984
Targeting multidrug resistance in cancer
Gergely Szakács (2006)
10.1371/journal.pone.0158084
Magnetic Properties of Polyvinyl Alcohol and Doxorubicine Loaded Iron Oxide Nanoparticles for Anticancer Drug Delivery Applications
Muhammad Nadeem (2016)
10.1039/b614735f
Heterostructured magnetic nanoparticles: their versatility and high performance capabilities.
Young-wook Jun (2007)
10.1016/j.biomaterials.2010.01.010
PET/NIRF/MRI triple functional iron oxide nanoparticles.
Jin Xie (2010)
Human serum albumin coated iron oxide nanoparticles for efficient cell labelling
J Xie (2010)
10.1201/9781315168258
Clinical Applications of Magnetic Nanoparticles : From Fabrication to Clinical Applications
Nguyen Tk Thanh (2018)
10.1021/la063415s
Relaxometric and magnetic characterization of ultrasmall iron oxide nanoparticles with high magnetization. Evaluation as potential T1 magnetic resonance imaging contrast agents for molecular imaging.
Elena Taboada (2007)
10.1039/b917195a
Human serum albumin coated iron oxide nanoparticles for efficient cell labeling.
Jin Y. Xie (2010)
10.1088/1674-1056/23/3/037503
Magnetic iron oxide nanoparticles: Synthesis and surface coating techniques for biomedical applications
Sun Sheng-nan (2014)
10.1016/J.PCRYSGROW.2008.08.003
Synthesis, properties, and applications of magnetic iron oxide nanoparticles
Amyn S. Teja (2009)
10.1039/b902394a
Superparamagnetic iron oxide nanoparticles: from preparations to in vivo MRI applications
Ruirui Qiao (2009)
10.1016/j.jconrel.2014.03.057
EPR: Evidence and fallacy.
Joseph W. Nichols (2014)
10.2147/IJN.S63433
Development and characterization of magnetic iron oxide nanoparticles with a cisplatin-bearing polymer coating for targeted drug delivery
Harald Unterweger (2014)
10.1016/j.jconrel.2016.01.006
Poly-paclitaxel/cyclodextrin-SPION nano-assembly for magnetically guided drug delivery system.
Hyeon-Jeong Jeon (2016)
10.2147/IJN.S139011
Double-receptor-targeting multifunctional iron oxide nanoparticles drug delivery system for the treatment and imaging of prostate cancer
Md Shakir Uddin Ahmed (2017)
10.1021/nl035253f
Synthesis of Fe Oxide Core/Au Shell Nanoparticles by Iterative Hydroxylamine Seeding
Jennifer L. Lyon (2004)
10.1016/j.ijpharm.2011.06.010
A pharmaceutical study of doxorubicin-loaded PEGylated nanoparticles for magnetic drug targeting.
Jean Pierre Gautier (2012)
10.1016/j.jhazmat.2010.04.105
Water purification using magnetic assistance: a review.
Ritu D. Ambashta (2010)
10.1002/mrm.1910340507
Application of a superparamagnetic iron oxide (Resovist) for MR imaging of human cerebral blood volume.
Peter Reimer (1995)
10.1002/jmri.22683
Coronary MR angiography using citrate-coated very small superparamagnetic iron oxide particles as blood-pool contrast agent: initial experience in humans.
Moritz Wagner (2011)
10.1088/1361-6528/aabbd0
VSION as high field MRI T1 contrast agent: evidence of their potential as positive contrast agent for magnetic resonance angiography.
Thomas Vangijzegem (2018)
10.1016/j.colsurfb.2014.12.041
Nanotechnological carriers for cancer chemotherapy: the state of the art.
Marilene Estanqueiro (2015)
10.1109/TMAG.1981.1061188
Preparation of aqueous magnetic liquids in alkaline and acidic media
Rene. Massart (1981)
10.1016/j.matlet.2004.03.045
Properties of magnetite nanoparticles synthesized through a novel chemical route
Deepa Thapa (2004)
10.1021/nn3043463
Theranostic nanoparticles with controlled release of gemcitabine for targeted therapy and MRI of pancreatic cancer.
Gee Young Lee (2013)
10.1680/BBN.12.00014
Magnetic iron oxide nanoparticles: synthesis and applications
Chengyin Fu (2012)
10.1088/0957-4484/27/6/065103
Multifunctionalized iron oxide nanoparticles for selective drug delivery to CD44-positive cancer cells.
Antonio Aires (2016)
10.1200/JCO.1990.8.7.1263
Hypersensitivity reactions from taxol.
Raymond B. Weiss (1990)
10.1016/j.biomaterials.2004.10.012
Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications.
Ajay Kumar Gupta (2005)
10.1097/FPC.0b013e32833ffb56
Doxorubicin pathways: pharmacodynamics and adverse effects
Caroline F. Thorn (2011)
10.1039/C3TB21480J
Carboxy-silane coated iron oxide nanoparticles: a convenient platform for cellular and small animal imaging.
Dimitri Stanicki (2014)
10.1166/JBN.2016.2298
Doxorubicin-Conjugated Heparin-Coated Superparamagnetic Iron Oxide Nanoparticles for Combined Anticancer Drug Delivery and Magnetic Resonance Imaging.
Yi Yang (2016)
10.1016/S0305-7372(03)00097-5
Mode of action of docetaxel - a basis for combination with novel anticancer agents.
Roy S. Herbst (2003)
10.1016/j.addr.2010.05.006
Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy.
Morteza Mahmoudi (2011)
10.1634/theoncologist.8-6-508
Velcade: U.S. FDA approval for the treatment of multiple myeloma progressing on prior therapy.
Robert C. Kane (2003)
10.1016/j.biopha.2014.12.012
Doxorubicin-loaded mesoporous magnetic nanoparticles to induce apoptosis in breast cancer cells.
Yan Yan Zou (2015)
10.1016/j.ijpharm.2018.03.030
Current development in the formulations of non‐injection administration of paclitaxel
Xiyou Du (2018)
• The authors developed magnetic nanocarriers carrying doxorubicin through an original approach using a pre-formed DOX-Fe 2+ complex in a simple protocol
10.1021/ja203340u
Large-scale synthesis of uniform and extremely small-sized iron oxide nanoparticles for high-resolution T1 magnetic resonance imaging contrast agents.
Byung Hyo Kim (2011)
10.1016/j.jconrel.2012.03.020
Doxil®--the first FDA-approved nano-drug: lessons learned.
Yechezkel Chezy Barenholz (2012)
10.1016/j.msec.2016.09.052
Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer theranostics.
Yinping Huang (2017)
Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer
Y Huang (2017)
10.1039/c5nr04867b
Anti-HER2/neu peptide-conjugated iron oxide nanoparticles for targeted delivery of paclitaxel to breast cancer cells.
Qingxin Mu (2015)
10.1016/j.addr.2011.03.008
Magnetic nanomaterials for hyperthermia-based therapy and controlled drug delivery.
Challa S. S. R. Kumar (2011)
10.1021/mp200006f
HSA coated iron oxide nanoparticles as drug delivery vehicles for cancer therapy.
Qimeng Quan (2011)
10.1016/j.tibtech.2011.03.001
Cancer theranostics: the rise of targeted magnetic nanoparticles.
Adam J. Cole (2011)
10.1155/2012/608298
Synthesis and Characterization of Iron Oxide Nanoparticles and Applications in the Removal of Heavy Metals from Industrial Wastewater
Zuolian Cheng (2012)
10.1016/j.ejphar.2014.07.025
Cisplatin in cancer therapy: molecular mechanisms of action.
Shaloam R. Dasari (2014)
10.1038/bjc.1997.63
Enhanced expression of urokinase plasminogen activator and its receptor in pancreatic carcinoma.
Daniel Cantero (1997)
10.3322/caac.21332
Cancer statistics, 2016.
Rebecca L Siegel (2016)
10.1088/1361-6528/aaae59
Influence of experimental parameters on iron oxide nanoparticles properties synthesized by thermal decomposition: size and nuclear magnetic resonance studies.
Sarah Belaid (2018)
10.2147/IJN.S68539
Development of a lauric acid/albumin hybrid iron oxide nanoparticle system with improved biocompatibility
Jan Zaloga (2014)
10.1021/acs.accounts.5b00038
Chemical synthesis and assembly of uniformly sized iron oxide nanoparticles for medical applications.
Daishun Ling (2015)
10.1038/srep21417
An MRI-based classification scheme to predict passive access of 5 to 50-nm large nanoparticles to tumors
Anastassia Karageorgis (2016)
10.2334/JOSNUSD.56.119
Chitosan exerts anticancer activity through induction of apoptosis and cell cycle arrest in oral cancer cells.
Yuniardini S Wimardhani (2014)
10.2174/156800911794519752
Bortezomib as the first proteasome inhibitor anticancer drug: current status and future perspectives.
D. I. Chen (2011)
10.1021/cr068445e
Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications.
Sophie Laurent (2008)
10.1039/c5nr02718g
Multifunctional superparamagnetic iron oxide nanoparticles for combined chemotherapy and hyperthermia cancer treatment.
Christopher A Quinto (2015)
10.1007/s00330-002-1721-7
Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications
Peter Reimer (2002)
10.1016/j.ejpb.2015.03.018
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Edgar Pérez-Herrero (2015)
10.1016/j.biotechadv.2015.02.003
Tailored functionalization of iron oxide nanoparticles for MRI, drug delivery, magnetic separation and immobilization of biosubstances.
Kateřina Holá (2015)
10.3390/medsci6010019
Artemisinin and Its Synthetic Derivatives as a Possible Therapy for Cancer
Enrique Konstat-Korzenny (2018)
10.1016/J.PORGCOAT.2015.05.023
A review of current coupling agents for modification of metal oxide nanoparticles
Shadpour E. Mallakpour (2015)
10.1021/CM300301C
Superparamagnetic MFe2O4 (M = Fe, Co, Mn) Nanoparticles: Tuning the Particle Size and Magnetic Properties through a Novel One-Step Coprecipitation Route
Clara Pereira (2012)
10.1016/J.ICA.2012.05.012
Cisplatin drug delivery using gold-coated iron oxide nanoparticles for enhanced tumour targeting with external magnetic fields
Amelia J. Wagstaff (2012)
10.1007/s11051-012-0964-8
Synthesis optimization and characterization of chitosan-coated iron oxide nanoparticles produced for biomedical applications
Gozde Unsoy (2012)



This paper is referenced by
10.1016/j.ijbiomac.2019.10.272
Methotrexate-conjugated chitosan-grafted pH- and thermo-responsive magnetic nanoparticles for targeted therapy of ovarian cancer.
Marziyeh Fathi (2019)
10.1007/978-3-030-16439-3_6
Magnetic Nanoparticles: A Unique Gene Delivery System in Plant Science
Mohamed A. Mohamed (2019)
10.3390/nano10040757
Influence of Experimental Parameters of a Continuous Flow Process on the Properties of Very Small Iron Oxide Nanoparticles (VSION) Designed for T1-Weighted Magnetic Resonance Imaging (MRI)
Thomas Vangijzegem (2020)
10.3390/magnetochemistry6010002
Magnetic Nanoparticle Systems for Nanomedicine—A Materials Science Perspective
V Socoliuc (2020)
10.1080/21691401.2020.1748885
ZnO/CNT@Fe3O4 induces ROS-mediated apoptosis in chronic myeloid leukemia (CML) cells: an emerging prospective for nanoparticles in leukemia treatment.
Amir-Mohammad Yousefi (2020)
Magnetic nanoparticles (MNPs) a promising drug delivery of anticancer agents: A review
Sharda Shinde (2020)
10.1039/c9nr08436c
Metronidazole-functionalized iron oxide nanoparticles for molecular detection of hypoxic tissues.
Miriam Filippi (2019)
10.1126/sciadv.aax6040
Sight and switch off: Nerve density visualization for interventions targeting nerves in prostate cancer
Huijuan You (2020)
10.3390/cancers11060867
Nobiletin and Derivatives: Functional Compounds from Citrus Fruit Peel for Colon Cancer Chemoprevention
Joanna Xuan Hui Goh (2019)
10.3390/nano10020276
Nanocarriers as Magic Bullets in the Treatment of Leukemia
Mohammad Houshmand (2020)
10.2147/IJN.S254745
A New Pharmacokinetic Model Describing the Biodistribution of Intravenously and Intratumorally Administered Superparamagnetic Iron Oxide Nanoparticles (SPIONs) in a GL261 Xenograft Glioblastoma Model
Alexander P Klapproth (2020)
10.1088/1361-6528/ab70d0
A multiparametric model for the industrialization of co-precipitation synthesis of nano-commodities.
Lilian C Alarcon Segovia (2020)
10.1016/j.eurpolymj.2020.109584
In situ preparation of non-viral gene vectors with folate/magnetism dual targeting by hyperbranched polymers
Yunfeng Shi (2020)
10.1002/wnan.1605
Recent developments in the use of organic-inorganic nanohybrids for drug delivery.
Danushika C. Manatunga (2019)
10.1016/j.apsusc.2019.143963
Functionalized Iron Oxide Nanoparticles Conjugate of Multi-Anchored Schiff’s Base Inorganic Heterocyclic Pendant Groups: Cytotoxicity Studies
Dinesh Kumar Chelike (2020)
10.1016/j.jallcom.2019.152802
Direct synthesis of 3D flower-like maghemite particles and their properties
Bao-yan Zhang (2020)
10.1016/j.jddst.2019.101493
Magnetic nanocarriers: Emerging tool for the effective targeted treatment of lung cancer
Janani Sadhasivam (2020)
10.1039/c9ra10047d
Augmented interaction of multivalent arginine coated gold nanoclusters with lipid membranes and cells
Estelle Porret (2020)
10.3390/magnetochemistry5040061
Synthesis, Properties and Applications of Magnetic Nanoparticles and Nanowires—A Brief Introduction
Evgeny Katz (2019)
10.3390/CATAL9080691
Cerium- and Iron-Oxide-Based Nanozymes in Tissue Engineering and Regenerative Medicine
Michelle M. T. Jansman (2019)
10.1016/j.jconrel.2020.01.052
The clearance and biodistribution of magnetic composite nanoparticles in healthy and osteoarthritic rat knees.
Brittany D Partain (2020)
10.1007/978-981-15-0391-7_9
Green Nanoparticles for Biomedical and Bioengineering Applications
Luciano Prado da Silva (2020)
10.1007/978-981-15-0391-7
Nanoparticles and their Biomedical Applications
Ajit Kumar N. Shukla (2020)
10.1016/j.ijbiomac.2020.01.162
Synthesis of micelles based on chitosan functionalized with gold nanorods as a light sensitive drug delivery vehicle.
Ali Pourjavadi (2020)
10.1016/j.jddst.2020.101621
Chitosan-coated magnetic solid lipid nanoparticles for controlled release of letrozole
Zeynab Ahmadifard (2020)
10.5772/INTECHOPEN.85748
Magnetic Bio-Derivatives: Preparation and Their Uses in Biotechnology
Mariana Paola Cabrera (2019)
10.1080/07391102.2019.1650114
Fabrication and Evaluation of Anti-Cancer Efficacy of Lactoferrin-Coated Maghemite and Magnetite Nanoparticles.
Majid Sharifi (2019)
10.1103/physrevapplied.12.034041
Nonharmonic Driving Fields for Enhancement of Nanoparticle Heating Efficiency in Magnetic Hyperthermia
Paolo Allia (2019)
10.2217/nnm-2019-0428
Chemotherapeutic potential of L-carnosine from stimuli-responsive magnetic nanoparticles against breast cancer model.
Ragwa Mohamed Farid (2020)
Semantic Scholar Logo Some data provided by SemanticScholar